Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
TMA-6 is largely considered to be not habit-forming, with users reporting that the desire to use it can actually decrease with consumption. It is most often self-regulating.
The exact toxic dose is unknown due to very limited history of human usage. No systematic toxicity studies have been conducted.
TMA-6 emerged from Alexander Shulgin's systematic exploration of trimethoxyamphetamines. After discovering that relocating a single methoxy group from the original TMA (3,4,5-trimethoxyamphetamine) to create TMA-2 resulted in a ten-fold increase in potency, Shulgin prioritized investigating all six…
Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) since November 26, 2016. Production and import with intent to distribute, administration to others, and trading are criminally punishable offenses. Possession is prohibited but does not carry criminal penalties.
Classified as a controlled drug under national legislation. Possession, production, supply, and importation are all prohibited.
Not explicitly scheduled by name. However, it may be considered an ether analog of PMA, which could render it controlled under Buchstabe C of the Swiss controlled substances regulations.
10 sources cited